GSK1325756 - first doses in humans; version 1

• Research type

  Research Study

• Full title

  A single-centre, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single, oral, ascending doses and repeat oral doses of GSK1325756 in healthy male subjects (HMR code 09-007).

• IRAS ID

  31330

• Sponsor organisation

  GlaxoSmithKline

• Eudract number

  2009-013130-24

• ISRCTN Number

  N/A

• Clinicaltrials.gov Identifier

  N/A

• Research summary

  N/A

• REC name

  London - Brent Research Ethics Committee

• REC reference

  09/H0717/66

• Date of REC Opinion

  23 Oct 2009

• REC opinion

  Further Information Favourable Opinion